Decoding the Data: Understanding the Impact of Study Bias in the Clinical Evaluation of Skin Substitutes in Chronic Wounds
Click HERE to view.
This session will assess the differences in the quality of clinical trials on the use of skin substitutes in chronic wounds, specifically focusing on the importance of identifying inherent bias in clinical study design in the age of evidence-based medicine. This symposium will also include an overview of the recent Agency for Healthcare Research & Quality (AHRQ) 2020 Technical Assessment on Skin Substitutes document and include a brief review of the MiMedx clinical studies that were evaluated in the ARHQ document.
Frances L. Game BSc(Hons), MBBCh(Hons), FRCP
Consultant Diabetologist and Director of R&D
Derbyshire, England, UK
William H. Tettelbach, MD, FACP, FIDSA, FUHM, CWS
Associate Chief Medical Officer MiMedx
This webinar program is sponsored by: